Influence of glutamate-evoked pain and sustained elevated muscle activity on blood oxygenation in the human masseter muscle Suzuki S, Arima T, Kitagawa Y, Svensson P, Castrillon E. Influence of glutamateevoked pain and sustained elevated muscle activity on blood oxygenation in the human masseter muscle. Eur J Oral Sci 2017; 125: 453-462. © 2017 Eur J Oral Sci This study aimed to investigate the effect of glutamate-evoked masseter muscle pain on intramuscular oxygenation during rest and sustained elevated muscle activity (SEMA). Seventeen healthy individuals participated in two sessions in which they were injected with glutamate and saline in random order. Each session was divided into three, 10-min periods. During the first (period 1) and the last (period 3) 10-min periods, participants performed five intercalated 1-min bouts of masseter SEMA with 1-min periods of 'rest'. At onset of the second 10-min period, glutamate (0.5 ml, 1 M; Ajinomoto, Tokyo, Japan) or isotonic saline (0.5 ml; 0.9%) was injected into the masseter muscle and the participants kept the muscle relaxed in a resting position for 10 min (period 2). The hemodynamic characteristics of the masseter muscle were recorded simultaneously during the experiment by a laser blood-oxygenation monitor. The results demonstrated that glutamate injections caused significant levels of self-reported pain in the masseter muscle; however, this nociceptive input did not have robust effects on intramuscular oxygenation during rest or SEMA tasks. Interestingly, these findings suggest an uncoupling between acute nociceptive activity and hemodynamic parameters in both resting and lowlevel active jaw muscles. Further studies are needed to explore the pathophysiological significance of blood-flow changes for persistent jaw-muscle pain conditions.
Orofacial pain disorders are highly prevalent and debilitating conditions associated with significant psychosocial distress and high levels of health-care utilization (1) (2) (3) . Among the various orofacial pain conditions, pain-related temporomandibular disorders (TMD) are some of the most common causes of orofacial pain (1) and they have traditionally been assumed to be linked to hyperactivity or abnormal contraction of the masticatory muscles (4) (5) (6) (7) (8) . The background for this assumption is the frequent clinical observation that many patients with TMD apparently exhibit a tendency to clench or grind their teeth (9) (10) (11) , although tooth grinding is not necessarily associated with a higher risk of transient pain; thus, the relationship between bruxism and TMD pain is not likely to be a linear one (12, 13) . Nevertheless, a large number of studies have described TMD-like pain evoked by prolonged sustained elevated muscle activity (SEMA), such as the experimental bruxism models (14) (15) (16) (17) (18) (19) (20) . Interestingly, when such experimental clenching tasks are repeated over 3 or 5 d, the pain and fatigue ratings decrease after the first day, indicating that SEMA can indeed cause muscle symptoms but that these are self-limiting in healthy individuals (21) .
Moreover, human experimental-muscle pain models are also used to investigate underlying mechanisms of the myalgic TMD pain. It has been shown that injection of glutamate (0.1-1 M) into the masseter muscle evokes pain through activation of peripheral N-methyl-D-aspartate (NMDA) receptors in healthy individuals and that this pain resembles some of the aspects of the muscle pain in patients with myalgic TMD (22) (23) (24) (25) (26) (27) (28) .
In terms of underlying muscle pain mechanisms, localized intramuscular hemodynamic disturbances, leading to a lower level of oxygen distribution and hypoxia, have been proposed to play an important role in the chronic painful muscle (29) (30) (31) . Using a nearinfrared method, DELCANHO et al. (32) demonstrated lower concentrations of total hemoglobin (Total-Hb) in the masseter muscle immediately after submaximal isometric contractions in patients with chronically painful masticatory muscles compared with the levels seen in healthy participants. ACERO et al. (33) also utilized the near-infrared method and assessed hemodynamic changes in patients with chronic localized muscle pain and showed that the intramuscular hemoglobin levels were significantly reduced during cold pressor stimulation. This phenomenon may represent only a secondary characteristic of the pain-inducing mechanism or it might be a fundamental aspect of the primary process causing pain (34) . Our recent study suggested that different levels of repeated (30 times in each level) SEMA of the masseter muscles in healthy participants were associated with distinct hemodynamic characteristics in addition to muscle symptoms, such as pain and fatigue (35) . However, it is still unknown how an acute painful condition may influence the hemodynamic parameters and the previously observed differences in hemodynamic parameters caused by SEMA.
The aim of this study was therefore to investigate the effect of glutamate-evoked masseter muscle pain on intramuscular oxygenation during rest and SEMA. It was hypothesized that glutamate-evoked pain following SEMA may lead to a perturbation of the hemodynamic parameters in the masseter muscles.
Material and methods

Participants
A total of 17 healthy participants (11 men and six women), mean age AE SD = 27.6 AE 6.6 yr, were enrolled. The participants were recruited by advertising the experiment through posting flyers in Aarhus University, Denmark, and in a webpage (www.forsoegsperson.dk). Participants were included if they were between 18 and 40 yr of age. Questionnairebased exclusion criteria were: ongoing pain; chronic pain during the last 6 months; systemic diseases (e.g. metabolic diseases, neurogenic diseases and cardiovascular disorders); previous radiotherapy or chemotherapy; intake of any medicine affecting the nervous system in the 24 h before the experiments; and physical or mental disorders. The participants had no signs or symptoms of TMD according to the diagnostic criteria for temporo mandibular disorders (DC/ TMD) screener (36) . It was confirmed that none of the participants took medication that could influence psychological and/or cardiovascular responses. The experimental protocol was approved by the local Ethics Committee Region Midt (Denmark) (case No.1-10-72-201-15), in accordance with the Declaration of Helsinki. The participants were informed about their right to withdraw from the study at any time and they signed an informed consent form.
Study design
In this cross-over experiment, the participants were requested to attend two sessions, in one of which they were injected with glutamate and in the other with isotonic saline, in random order (Fig. 1) . Each session was divided into three periods (periods 1, 2, and 3), each of 10 min duration. At specific time points, the participants were asked to perform two different tasks (SEMA or rest). During the first 10 min (period 1), the participants performed intercalated SEMA and rest tasks. After period 1, an intramuscular injection of glutamate (0.5 ml, 1 M) or isotonic saline (0.5 ml; 0.9%) was given into the right masseter muscle. After the injection, the participants kept the masticatory muscles relaxed in a resting position, without having the teeth in contact, for 10 min (period 2). Subsequently (period 3), participants repeated the intercalated SEMA and rest tasks, which were the same as described for period 1. Assessment of pain, fatigue, and unpleasantness was performed during the experiment. Intramuscular blood oxygenation of the masseter muscle was recorded continuously throughout the duration of the experiment. In the second session, participants performed exactly the same tasks and procedures as described for the first Fig. 1 . Schematic illustration of the experimental protocol. Participants took part in two sessions. Each session was divided into three periods; participants performed sustained elevated muscle activity (SEMA) tasks in periods 1 and 3, and they received injections of glutamate or isotonic saline at the start of period 2. Numerical rating scale (NRS) scores for pain, fatigue, and unpleasantness were rated during rest periods (of 1 min duration after each SEMA). Electronic visual analog scales (eVAS) were assessed in period 2. A laser blood-oxygenation monitor (BOM) recorded the hemodynamic characteristics during the whole experimental session. BL, baseline; DC/TMD, diagnostic criteria for temporomandibular disorders. session, only this time there was a cross-over of the type of solution being injected. The two sessions were scheduled at least 5 d apart, and the order of injection (glutamate or saline) was randomly selected.
Sustained elevated muscle activity
The participants performed a maximal voluntary occlusal bite force (MVOBF) test at the beginning of the experimental session, following the methodology described by DAWSON et al. (37) . The MVOBF was measured in Newton (N) by asking the participants to bite on a bite force transducer (41.0 9 12.0 9 5.0 mm, length 9 width 9 height; Aalborg University, Aalborg, Denmark) between the first or second molars on the right side. The analog output of the amplifier was connected to an analog-to-digital converter (BNC-2090; National Instruments, Austin, TX, USA), and the bite force signal was analog-to-digital converted, sampled at 2 kHz, and stored on a personal computer (PC) for later analysis. To stabilize and hold the end of the transducer between the upper and lower teeth, a layer of acrylic resin of 2 mm thickness and silicone impression material (President Putty; Coltene, Altstaetten, Switzerland) were added onto the bite force transducer and fitted to the occlusion. The MVOBF was determined as the mean calculated from three consecutive MVOBF efforts for 2-3 s with an interval of about 3 s. The assessment was performed in triplicate and the mean was calculated. The mean value of the three MVOBF assessments served to define the 40% of MVOBF as the target force level. This force level was decided based on our previous study (35) , which showed that the relative changes of total hemoglobin were greater during SEMA at 40% MVOBF than at 10% MVOBF.
The participants underwent five, 1-min bouts of 40% MVOBF as SEMA (SEMA 1-5) with intervals of 1 min of rest (rest 1-5) between the bouts (Fig. 1) . The participants were then instructed to observe the bite force display as a feedback to ensure that the biting force was kept constant during the SEMA. The examiner continuously supervised and encouraged the participants to maintain the target force level.
Intramuscular injection of glutamate and isotonic saline
The participants received an injection on the right side of the masseter muscle in each session at the start of period 2 ( Fig. 1 ). The solution injected was a sterile solution of either monosodium glutamate (0.5 ml; 1 M) or isotonic saline (0.5 ml; 0.9%). Sterile monosodium glutamate solution for injection was prepared by Skanderborg Hospital Pharmacy (28) (pH 6.9, as assessed using a PHM 93 Reference pH Meter; Radiometer, Brønshøj, Denmark). All injections were given manually over a 10-s period with a 27-gauge hypodermic needle (Sterican; B. Braun Medical, Frederiksberg, Denmark) and a disposable syringe into the masseter muscle. The needle was inserted about 20 mm into the muscle at a 45°angle to the skin surface, so that the tip of the needle was around 14-15 mm in depth from the skin surface. The site of the injection was approximately 15 mm behind the bulkiest point of the masseter muscle on which the detector 1 of the blood-oxygenation monitor (BOM) device (see below) was placed.
Both participant and experimenter were blinded with respect to the order of the solution injected, which was randomly determined. An assistant who had no clinical function in this experiment performed the randomization process using the website http:/www.randomization.com.
Assessment of pain, fatigue, and unpleasantness
During period 2 the participants were asked to score continuously the pain intensity on an electronic visual analog scale (eVAS) [(Foresee-IMC Scale (VAS); Interactive Minds Centre, Aarhus, Denmark] of 0-10, for which the lower end of the scale was marked 'no pain' and the upper end was marked 'most pain imaginable' (Fig. 1) . The eVAS software was run on a Windows (7 Enterprise 2009 Service Pack 1, Hewlett Packard 8100 Compaq Elite SFF) PC and the participant controlled the scale with a mouse. The participants were able to see the score on the screen of the PC, thereby providing live feedback. The data were sampled every 1 s and stored automatically in a table in Microsoft Excel.
During periods 1 and 3, the perceived levels of pain, fatigue, and unpleasantness were evaluated intermittently by the participants using three separate numerical rating scales (of 0-10), with the '0' end representing 'no pain, no fatigue, or no unpleasantness' and the '10' end representing 'the highest pain, highest fatigue, or highest unpleasantness imaginable' at predetermined time points. The scoring of pain during SEMA was carried out during rest periods immediately after the SEMA period had finished, as a recall assessment of pain during SEMA (Fig. 1) .
Intramuscular blood oxygenation
The hemodynamic characteristics were assessed from the right masseter muscle with the use of a laser BOM (BOM-L1TRW; OMEGAWAVE, Tokyo, Japan) using the methodology previously described (35) . The BOM recording device had one probe and two detectors. The lights from the probe were scattered and absorbed in the tissue, and part of those scattered lights were detected by the two detectors. The distance from the probe to the nearest detector was 1 cm, whereas the second detector was placed 2 cm from the probe. The absorption of the lights in the tissue was mainly caused by hemoglobin, and the absorption spectra of oxygenated hemoglobin (Oxy-Hb) and deoxygenated hemoglobin (Deoxy-Hb) were different. The oxygenated blood volume and the deoxygenated blood volume were calculated from the changes detected in the laser light intensity (38, 39) . The device was placed in the middle of the right masseter muscle parallel to the main directions of muscle fibers, as determined from palpation of the muscles. The detector 1, which was closer to the light source, was placed close to the bulkiest point of the muscle found in the lower third of the muscle, as determined by manual palpation, while asking the subject to clench their teeth for a few seconds (35) .
The following parameters were derived from the BOM: (i) Oxy-Hb; (ii) Deoxy-Hb; (iii) total hemoglobin (TotalHb); and (iv) tissue blood oxygen saturation (StO 2 ). TotalHb and StO 2 were calculated based on the values obtained for Oxy-Hb, and Deoxy-Hb (39) . These analog outputs were connected to a data-acquisition system (IX-404E; iWorx Systems, Dover, NH, USA), which was managed by a recording software (LabScribe2; iWorx Systems) that sampled at a rate of 10 samples per second per channel in each of its four channels. These data were stored on a 
Statistics
All data are expressed as mean AE standard error of the mean.
Analysis of intramuscular blood oxygenation
The baseline values (defined as the 1-min period before starting the SEMA task on the first period of the first session; Fig. 1 ) of each parameter (Oxy-Hb, Deoxy-Hb, Total-Hb, and StO 2 ) were tested by t-tests to determine if there were any gender differences.
For the analysis of hemodynamic parameters, the data were averaged for every 1 min to observe changes over time. Each BOM parameter (Oxy-Hb, Deoxy-Hb, TotalHb, and StO 2 ) was analyzed using relative changes from their baseline value. The 5-s transition periods from rest to SEMA and from SEMA to rest were excluded for all periods in order to avoid the influences of opening and closing of the mouth during the SEMA tasks (periods 1 and 3). The BOM data obtained were analyzed using a two-way ANOVA, with session and time as factors, to determine if there were statistically significant differences between the two different injection types at any of the four BOM outcomes. The two-way ANOVA was performed separately for each period (periods 1, 2, and 3) and for each task (SEMA, rest) with the exception of period 2, which was recorded with the jaws at rest.
The average values of the five values for each task in each period (periods 1 and 3) were calculated. Differences between tasks were tested within periods 1 and 3. Differences between periods were compared using paired t-tests within sessions (glutamate or saline).
Analysis of bite force data
The results of the MVOBF were compared using a twoway ANOVA, with gender (men and women) and session (glutamate and saline) as factors.
The results of the bite force recorder during SEMA were averaged for each 1-min SEMA and were tested by three-way ANOVA with the following factors: session (glutamate and saline); period (periods 1-3); and time (SEMA 1-5).
Analysis of experimentally evoked pain data
The results of eVAS during period 2 were also averaged for every 1 min (overall pain) and compared using a twoway ANOVA using sessions (glutamate or saline) and time (0-10 min) as factors. The eVAS outcome parameterspeak of the pain (eVAS peak), duration of the pain (eVAS duration), and area under the curve (eVAS AUC) -were tested using paired t-tests.
A two-way ANOVA was used to analyze the scores of pain, fatigue, and unpleasantness in each of the periods (periods 1-3) separately, with session (glutamate or saline) and time (SEMA 1-5/rest 1-5) as factors.
Post hoc comparisons were performed using Tukey's Honest Significant Difference (HSD) tests with correction for multiple comparisons. The STATISTICA software (StatSoft, Tulsa, OK, USA) was used for all analyses. The statistical significance level was 0.05. There were no missing data.
Results
SEMA
The mean AE standard error of the mean MVOBF was 377.3 AE Figure 2 shows the results of the actual percentage of the bite force during the SEMA tasks period. All participants completed the SEMA tasks with the bite force average corresponding to 37.9 AE 0.1% of the MVOBF. Three-way ANOVA showed no significant effects of factor and no statistically significant interactions (P > 0.435). Figure 3 demonstrates the overall pain assessed on the eVAS for period 2. Regarding the overall pain averaged for 1 min, the two-way ANOVA showed an interaction between session and time, and an overall effect of session and time (P < 0.001), with significantly higher pain scores for glutamate than for isotonic saline at every time point (P < 0.001, Tukey HSD test).
Intramuscular injection of glutamate and isotonic saline
Regarding eVAS peak, duration, and AUC, the t-tests showed significantly higher values in the glutamate session compared with the isotonic saline session (P < 0.001, Fig. 4 ). Figure 5 shows the mean scores in periods 1 and 3 of the recall pain during SEMA (Fig. 5A) , and pain (Fig. 5B), fatigue (Fig. 5C ), and unpleasantness (Fig. 5D ) during rest. The two-way ANOVA for period 1 showed only an overall time effect for recall pain during SEMA and for pain, fatigue, and unpleasantness during rest (P < 0.028). In period 3 there were overall time effects (P < 0.003) for all parameters and there were overall session effects (P < 0.045) for all parameters except for unpleasantness (P = 0.059). There were no statistically significant interactions (P > 0.220), with the exception of period 1 in pain during rest (P < 0.001). Fig. 3 . Perceived pain after injection. Electronic visual analog scales (eVAS) in the 10 min after intramuscular injection, with the '0' extreme representing 'no pain' and the '10' extreme representing 'the highest pain imaginable'. Each value represents the mean AE standard error of the mean (n = 17). Significant main effects of session and time (P < 0.001, two-way ANOVA). Fig. 4 . Peak, duration, and area under the curve (AUC) of pain after injection. Bar charts illustrate the mean AE standard error of the mean for the various electronic visual analog scale (eVAS) outcomes; peak of the pain (eVAS peak) (A), duration of the pain (eVAS duration) (B), and area under the curve (eVAS AUC) (C) in response to the intramuscular injection of glutamate or isotonic saline. †Significant differences between sessions (P < 0.001, t-tests).
Intramuscular blood oxygenation
Gender differences: There were no significant differences between genders for any of the BOM parameters at baseline (t-tests; P > 0.486).
Effects of SEMA on intramuscular oxygenation: In period 1, the two-way ANOVA of the relative changes of BOM parameters showed no session effects for SEMA or for rest tasks (P > 0.097). Overall, there were significant time effects for SEMA (P < 0.028), except for Deoxy-Hb (P = 0.064). There were also significant time effects for the rest tasks (P < 0.014), except for Total-Hb (P = 0.126). There were no statistically significant interactions (P > 0.189). t-tests showed that the relative changes of the SEMA task values were significantly higher than the relative changes measured during the rest tasks for Deoxy-Hb and Total-Hb (P < 0.001) and significantly lower for Oxy-Hb and StO 2 (P < 0.001) (Fig. 6) .
Effects of glutamate-evoked pain on intramuscular oxygenation: In period 2, the two-way ANOVA of the relative changes of BOM parameters showed interactions between session and time for Oxy-Hb and StO 2 (P < 0.049). There were no main effects of session (P > 0.052) for any BOM parameter but there was an overall effect of time for all BOM parameters (P < 0.030), except for Deoxy-Hb (P = 0.871). Post-hoc tests showed that the relative changes of Oxy-Hb were significantly increased 3 min after the injection of glutamate compared with 1 min after the injection of glutamate (P < 0.047). Post-hoc tests for StO 2 showed that the relative changes were significantly higher 3 and 4 min after injection of isotonic saline (P < 0.032). Meanwhile an increase in StO 2 was sustained only from 2 min onwards after injection of glutamate (P < 0.005). This resulted in significant differences between sessions from 6 min onwards (P < 0.011) (Fig. 6) .
Effect of SEMA on intramuscular oxygenation after glutamate-evoked pain: In period 3, the two-way ANOVA of the relative changes of BOM parameters showed no session effects for SEMA or for rest tasks (P > 0.082). Overall, there were no time effects of SEMA (P > 0.064), except for Oxy-Hb (P = 0.013). For the rest tasks, there were only time effects for Oxy-Hb and StO 2 (P < 0.011). There were no significant interactions (P > 0.391) (Fig. 6) . Each value represents the mean AE standard error of the mean (n = 17). There was an overall time effect in all parameters in both periods. *Significant overall period and time effect; †, Significant overall session effect in period 3; ‡, indicates significant differences at specific time point.
Effects of SEMA on intramuscular oxygenation before and after glutamate-evoked pain: Overall, the average values for SEMA and rest after injection with glutamate (period 3) were significantly increased compared with the values obtained before the injections (period 1) (P < 0.013) with the exception of Deoxy-Hb, which was significantly decreased (P = 0.006) during SEMA (Fig. 6) .
The values for SEMA were also significantly increased in period 3 compared with before period 1 (P < 0.001) in the isotonic saline session, except for Deoxy-Hb (P = 0.102).
Discussion
The results of the present study indicate that there were no robust effects of session (i.e. differences between glutamate or isotonic saline) in the hemodynamic parameters following either standardized SEMA or the relaxed jaw-muscle tasks.
Several and diverse factors, such as anatomical characteristics (e.g. the craniofacial morphology and thickness of the craniofacial muscles), physiological characteristics (e.g. age and gender), and mechanical characteristics (e.g. the bite-force recording system) are known to influence measurements of the bite force (40, 41) . In addition to these factors, measurements of MVOBF are also dependent on the motivation and cooperation of the participants (42). Therefore, perhaps different studies have found a wide range of values in terms of MVOBF. Unilateral measurement of MVOBF in the molar region averages between 300 and 600 N in healthy adults with natural teeth (43, 44) .
The mean MVOBF in this study was 279.9 AE 38.5 N (men: 320.0 AE 55.2 N, women: 241.0 AE 49.2 N), which was higher than that reported in our previous study (35) . The target percentage of MVOBF to be achieved by the participants during SEMA tasks was 40%. In the present study, the mean of the actual percentage of the bite force was 37.9 AE 0.1% during the SEMA tasks (Fig. 2) and this value was slightly higher than that reported in our previous study (32.7 AE 0.4%) (35) , even though the same targets of 40% MVOBF were requested. These minor discrepancies showed that despite similar experimental set-ups (the same MVOBF, the same researchers, the same set-ups, similar participant characteristics, etc.), the actual forces might vary between individuals and even within the same individuals. 
Blood oxygenation in masseter muscle
Many studies reported that the MVOBF is higher in men than in women because the jaw dimensions are larger in men than in women (45) (46) (47) (48) . Moreover, the muscle fibers might be different between genders, as a stronger bite force in men appears to be linked to a larger diameter and cross-sectional area of the type II fibers in the masseter muscle (49) . However, in the present study and in our previous study (35) there was no significant gender difference in the MVOBF. This lack of difference may be explained by the relatively small sample size used in both studies and that the studies were not designed to test specifically for gender differences.
As expected, the present study showed that intramuscular injection of glutamate (1.0 M, 0.5 ml) into the masseter muscle evoked pain (Figs 3 and 4) . The results presented in this study suggest that the duration of the glutamate-evoked pain was longer when it was preceded by a SEMA task. In previous studies, different volumes and concentrations of injections of glutamate (0.1-1 M and 0.2-0.5 ml) into the masseter muscle have been found to evoke about 5-10 min of muscle pain in healthy humans (23-25, 28, 50-52) . In the present study, almost all the participants reported pain until the end of the measurement of eVAS (10 min) (Fig. 3) . Even though we cannot compare our results directly with previous studies as a result of the different concentrations and volumes of glutamate used in each study it has been reported that similar levels of intensity of spontaneous pain can be evoked by injection of 0.5 M and 1.0 M glutamate into the human masseter muscle (23) . It has also been reported previously that different volumes (0.6 ml vs. 0.4 ml) of the same concentration (0.5 M) of glutamate injected into the splenius muscle did not result in any differences in pain intensity (50) . Moreover, it has been reported that injection of 0.5 ml of glutamate (i.e. the same volume as in the present study) did not result in pain lasting longer than 7 min when three different kinds of temperature injection of 0.5 M glutamate were used (51) . GAMBAROTA et al. suggested that it is the clearance of glutamate that determines the duration of glutamate-evoked pain response and that the clearance of glutamate in the masseter muscle is rapid and appears to be complete in rats 10 min after the injection (53) . They proposed that increased muscle blood flow would accelerate the rate at which intramuscularly injected glutamate could be absorbed into the systemic circulation and thus removed from the muscle tissue. Moreover, another previous animal study found that injection of hypertonic solutions, such as 1.0 M glutamate, into the masseter muscle significantly increased muscle blood flow (54) .
In the present study, we showed that after injections there was an increase in some of the hemodynamic parameters that may imply an increased blood flow and therefore an increase of clearance would be expected with a consequent decrease in the pain-evoked parameters. However, our study did not show this decrease in self-reported pain scores. We speculate that the lack of pain reduction, even in the presence of a possible increase in blood flow, may be caused by a (55, 56) , prostaglandins (57, 58) , cytokines (59, 60) , neuropeptides such as bradykinin (61) , and calcitonin gene-related peptide (62) , might be released in association with an experimental SEMA task and could contribute to the activation of muscle nociceptors (63) .
It could be speculated that, in our present study, performing the SEMA task before the glutamate injection might have influenced the duration of glutamateevoked pain; however, further investigations are needed to determine whether performing SEMA before the glutamate injection would interfere with the normal clearance of glutamate.
The scores for the recall pain during SEMA, and the scores of pain and fatigue during rest were significantly higher in the glutamate session than in the isotonic saline session in period 3 (Fig. 5) . A previous cross-over experimental study design, in which the participants performed a 10-min sustained 25% MVOBF before being injected with glutamate or isotonic saline, showed that there were no significant overall differences in scores of pain and fatigue (64) . Nevertheless, in this cited study, higher pain scores were reported in the glutamate session than in the isotonic saline session in the first 2 min following the injections (64) . This previous study also showed higher scores for pain and fatigue in the first 10 min of prolonged 25% MVOBF task before the injection when compared with our study. However, in our present study we applied 10 min of intermittent MVOBF of 1-min 40% MVOBF repeated five times with 1-min intervals. Taking all this information together, lower force levels (25% MVOBF) than our study (40% MVOBF) induced higher scores for pain and fatigue. These findings do, however, not align with our previous study report indicating that the 40% MVOBF task resulted in higher scores for pain and fatigue than similar SEMA tasks with lower MVOBF (10% MVOBF) (35) . These differences may be attributed to the specific subtype of MVOBF used in these studies (i.e. sustained MVOBF vs. intermittent MVOBF).
The present study showed that SEMA and rest tasks are associated with different hemodynamic responses in the human masseter muscle. The relative changes evoked by the SEMA tasks were higher compared with those evoked by the rest task for Deoxy-Hb and TotalHb and lower for Oxy-Hb and StO 2 (Fig. 6) . These results are in concordance with our previously published work (35) .
In terms of the effect of glutamate-evoked pain on blood flow, CAIRNS et al. showed that injection of hypertonic solutions, such as 1.0 M glutamate, into rat masseter muscle significantly increased muscle blood flow compared with injection of isotonic saline, for 10 min after the injection (54) . Our present study showed that the relative changes for all BOM parameters increased from baseline, not only in the glutamate session but also in the isotonic saline session, with the exception of Deoxy-Hb, which decreased only in the glutamate session (Fig. 6B) . The influence of bleeding/micro trauma in the muscle caused by the injection of either solution might have affected these results. However, the relative changes of StO 2 also increased in both the glutamate and isotonic saline sessions after the injection, but with significantly higher scores in the glutamate session at 6, 8, 9, and 10 min (Fig. 6D) . More research will be needed to find out the duration of blood oxygenation increases triggered by intramuscular administration of glutamate. These observed differences may nevertheless indicate that painful glutamate injections into the human masseter muscle can lead to minor and delayed differences in hemodynamic characteristics.
In terms of the effects of glutamate-evoked pain on the blood flow during the SEMA and rest tasks, there were no overall significant differences between sessions in the relative changes of the BOM parameters.
It is pertinent to point out that there are some limitations of the near-infrared method, which should be discussed in this study. First, the precise pathway of the reflected light through the illuminated tissue and the absolute blood volume can be assessed but is not exactly known (30) . Second, the signals from the skin vasculatures and blood vessels cannot be avoided; the device used in the present study may have measured not only the hemodynamic changes in the muscle but also some in the skin (30) . Moreover, FALLOW et al. suggested that the difference of the skin types tended to influence diffuse reflectance, even though this trend was not statically significant (65) . The sample size was relatively small, but the study was designed as a cross-over trial to minimize the influence of interindividual variability. Furthermore, the study was not specifically designed or powered to examine gender-related differences in hemodynamic characteristics. Further studies may be needed to test such aspects.
In conclusion, the findings presented suggest an uncoupling between acute nociceptive activity and hemodynamic parameters in both resting and low-level active jaw muscles. Further studies will be needed to explore the pathophysiological significance of blood flow changes for persistent jaw muscle pain conditions.
